📣 VC round data is live. Check it out!

MGI Tech Valuation Multiples

Discover MGI Tech's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Haemonetics, Integer Holdings, ICU Medical, Dr. Lal PathLabs and more.

MGI Tech Overview

About MGI Tech

MGI Tech Co Ltd is a producer of clinical high-throughput gene sequencers, and its multi-omics platforms include genetic sequencing, medical imaging, and laboratory automation. It provides real-time, panoramic, and full-life-cycle equipment and systems for precision medicine, precision agriculture, precision healthcare, and other relevant industries.


Founded

2016

HQ

China

Employees

N/A

Financials (LTM)

Revenue: $433M
EBITDA: $34M

EV

$3B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

MGI Tech Financials

MGI Tech reported last 12-month revenue of $433M and EBITDA of $34M.

In the same LTM period, MGI Tech generated $231M in gross profit, $34M in EBITDA, and had net loss of ($19M).

Revenue (LTM)


MGI Tech P&L

In the most recent fiscal year, MGI Tech reported revenue of $411M and EBITDA of $24M.

MGI Tech is unprofitable as of last fiscal year, with gross margin of 53%, EBITDA margin of 6%, and net margin of (8%).

See analyst estimates for MGI Tech
LTMLast FY202320242025202620272028
Revenue$433M$411M$430M$445M$411M
Gross Profit$231M$217M$256M$247M$217M
Gross Margin53%53%59%56%53%
EBITDA$34M$24M($39M)($16M)$24M
EBITDA Margin8%6%(9%)(4%)6%
EBIT Margin(5%)(6%)(16%)(13%)(6%)
Net Profit($19M)($32M)($90M)($89M)($33M)
Net Margin(4%)(8%)(21%)(20%)(8%)

Financial data powered by Morningstar, Inc.

MGI Tech Stock Performance

MGI Tech has current market cap of $3B, and enterprise value of $3B.

Market Cap Evolution


MGI Tech's stock price is $7.24.

MGI Tech share price decreased by 2.8% in the last 30 days, and by 23.1% in the last year.

MGI Tech has an EPS (earnings per share) of $-0.08.

See more trading valuation data for MGI Tech
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3B$3B0.4%-2.8%0.4%-23.1%$-0.08

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

MGI Tech Valuation Multiples

MGI Tech trades at 6.2x EV/Revenue multiple, and 79.2x EV/EBITDA.

See NTM and 2027E valuation multiples for MGI Tech

EV / Revenue (LTM)


MGI Tech Financial Valuation Multiples

As of June 3, 2026, MGI Tech has market cap of $3B and EV of $3B.

MGI Tech has a P/E ratio of (154.9x).

LTMLast FY202320242025202620272028
EV/Revenue6.2x6.5x6.2x6.0x6.5x
EV/EBITDA79.2x111.7x(68.1x)(170.2x)111.7x
EV/EBIT(117.1x)(110.1x)(38.9x)(47.8x)(110.1x)
EV/Gross Profit11.5x12.3x10.4x10.8x12.3x
P/E(154.9x)(92.8x)(33.6x)(34.0x)(91.9x)
EV/FCF(125.5x)n/m(11.1x)(15.6x)n/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified MGI Tech Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

MGI Tech Margins & Growth Rates

MGI Tech grew revenue by 14% and EBITDA by 139% in the last fiscal year.

In the most recent fiscal year, MGI Tech reported gross margin of 53%, EBITDA margin of 6%, and net margin of (8%).

See estimated margins and future growth rates for MGI Tech

MGI Tech Margins

Last FY202420252026202720282029
Gross Margin53%56%53%54%
EBITDA Margin6%(4%)6%12%
EBIT Margin(6%)(13%)(6%)(1%)
Net Margin(8%)(20%)(8%)(0%)
FCF Margin1%(38%)1%(12%)

MGI Tech Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth14%3%(8%)14%
Gross Profit Growth16%(3%)(12%)16%
EBITDA Growth139%(60%)(252%)139%
EBIT Growth(86%)(19%)(57%)(86%)
Net Profit Growth(95%)(1%)(63%)(95%)
FCF Growth(1624%)(29%)(102%)(1624%)

Data powered by FactSet, Inc. and Morningstar, Inc.

MGI Tech Operational KPIs

MGI Tech's Rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

MGI Tech's Rule of X is 48% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for MGI Tech
LTMLast FY202320242025202620272028
Rule of 4022%26%---
Bessemer Rule of X44%48%---
S&M Expenses to Revenue24%25%8%9%8%
G&A Expenses to Revenue16%16%12%5%3%
R&D Expenses to Revenue19%19%31%25%19%
Opex to Revenue-59%75%68%59%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Haemonetics3.0x3.0x10.1x10.0x
Integer Holdings2.4x2.4x11.0x11.3x
ICU Medical1.9x2.0x10.6x10.5x
Dr. Lal PathLabs10.1x8.7x31.5x30.9x
Autobio Diagnostics4.1x4.0x10.1x10.3x
Amplifon1.8x1.8x8.2x8.0x
Ambu2.8x2.7x14.6x14.7x
Carl Zeiss Meditec1.1x1.1x6.5x7.4x

This data is available for Pro users. Sign up to see all MGI Tech competitors and their valuation data.

Start Free Trial

MGI Tech VC Funding History

Before going public, MGI Tech raised $1B in total equity funding, across 2 rounds.

Last private valuation of MGI Tech was $5B, after raising $200M in May 2019 from CITIC Securities, Green Pine Capital Partners, Huagai Capital, and 1 other investor.


MGI Tech Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
May-20Series BBGI Co-Win; CITIC Securities; Cornerstone Capital; CPE Capital; Dinghang Capital; Green Pine Capital Partners; Guofang Capital; Huasheng Capital; Huatai Zijin Investment; IDG Capital; Titanium Capital$1B-MGI Tech, a gene sequencing technology developer and spinoff from BGI Group, completed a $1 billion Series B funding round on May 28, 2020, co-led by IDG Capital and CPE Capital, with participation from investors including Huasheng Capital, CITIC Securities affiliates, Green Pine Capital Partners, and others. The round followed a $200 million Series A in May 2019 and supported development of high-throughput sequencing systems for life sciences, precision medicine, agriculture, mass spectrometry, medical imaging, and laboratory automation, with applications in Covid-19 detection. MGI Tech listed on the Shanghai STAR Market in September 2022, raising CNY 3.6 billion at CNY 87.18 per share for a post-IPO market cap of around CNY 43.8 billion.
May-19Series ACITIC Securities; Green Pine Capital Partners; Huagai Capital; Orient Securities Capital Investment$200M$5BMGI Tech, a spinoff from BGI focused on gene sequencing technology, raised $200 million in its first funding round announced on May 9, 2019, from investors including Goldstone Investment (Citic Securities), Green Pine Capital Partners, and Orient Securities Capital Investment. The company had initially targeted a $1 billion round that would value it at $5 billion as reported in July 2018, but reduced the size due to slower-than-expected sales. MGI develops sequencing systems, reagents, and related products for life sciences, genetic testing, gene editing, and drug development, with over 1,100 sequencers delivered to customers in 16 countries. The funding supports international expansion, R&D for next-generation sequencers, new factory builds including one in Latvia, and broader applications in medical imaging and wearables. MGI reported a compound annual revenue growth rate exceeding 200% over the prior three years, capturing about one-third of the domestic Chinese market alongside competitors like Illumina and Thermo Fisher. Employee count reached around 900 globally by mid-2019. MGI, controlled by BGI's Wang Jian (nearly 80% stake), faced scrutiny over related-party sales, with BGI and affiliates purchasing 597 million yuan ($83.5 million) of products in 2019. The company later IPO'd in 2022 raising $520 million.

Acquisitions by MGI Tech

MGI Tech has acquired 2 companies to date.

Last acquisition by MGI Tech was on March 2nd 2026. MGI Tech acquired STOmics for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by MGI Tech

STOmics
CycloneSEQ
Description
STOmics is a spatial multi-omics startup that develops Stereo-seq technology for high-resolution tissue research.
CycloneSEQ is a developer of nanopore-based long-read sequencing technology. The company advances single-molecule nanopore sequencing from laboratory use into industrial applications.
HQ CountryChinaChina
HQ City
Changzhou
Hangzhou
Deal Date2 Mar 20262 Mar 2026
Valuationundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all MGI Tech acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About MGI Tech

When was MGI Tech founded?MGI Tech was founded in 2016.
Where is MGI Tech headquartered?MGI Tech is headquartered in China.
Is MGI Tech publicly listed?Yes, MGI Tech is a public company listed on Shanghai Stock Exchange.
What is the stock symbol of MGI Tech?MGI Tech trades under 688114 ticker.
When did MGI Tech go public?MGI Tech went public in 2022.
Who are competitors of MGI Tech?MGI Tech main competitors include Haemonetics, Integer Holdings, ICU Medical, Dr. Lal PathLabs, Autobio Diagnostics, Amplifon, Ambu, Carl Zeiss Meditec, Genscript Biotech, Lepu Medical Technology.
What is the current market cap of MGI Tech?MGI Tech's current market cap is $3B.
What is the current revenue of MGI Tech?MGI Tech's last 12 months revenue is $433M.
What is the current revenue growth of MGI Tech?MGI Tech revenue growth (NTM/LTM) is 15%.
What is the current EV/Revenue multiple of MGI Tech?Current revenue multiple of MGI Tech is 6.2x.
What is the current EBITDA of MGI Tech?MGI Tech's last 12 months EBITDA is $34M.
What is MGI Tech's EBITDA margin?MGI Tech's last 12 months EBITDA margin is 8%.
What is the current EV/EBITDA multiple of MGI Tech?Current EBITDA multiple of MGI Tech is 79.2x.
What is the current FCF of MGI Tech?MGI Tech's last 12 months FCF is ($21M).
What is MGI Tech's FCF margin?MGI Tech's last 12 months FCF margin is (5%).
What is the current EV/FCF multiple of MGI Tech?Current FCF multiple of MGI Tech is (125.5x).
How many companies MGI Tech has acquired to date?As of June 2026, MGI Tech has acquired 2 companies.
What was the largest acquisition by MGI Tech?None of the M&A deals MGI Tech has completed have disclosed valuations.
What companies MGI Tech acquired?MGI Tech acquired STOmics and CycloneSEQ.
In how many companies MGI Tech has invested to date?MGI Tech hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to MGI Tech

Lists including MGI Tech

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial